NIH / NSF SBIR Grant Success Rates

The success rate for NIH SBIR funding can be quite competitive. In recent years, the NIH has seen a success rate of approximately 15% for Phase I SBIR applications, and close to 31% for Phase II. This rate reflects the rigorous review process that prioritizes innovative projects with potential for significant impact on healthcare.

ONTOGEN MEDTECH SECURES ILLINOIS $50K SBIR MATCHING GRANT TO ADVANCE PARTNERSHIP WITH FLOW MEDICAL ON GROUNDBREAKING PULMONARY EMBOLISM CATHETER DEVICE.

Ontogen Medtech, a Chicago-based medical device design and development services company, has been awarded a $50,000 Small Business Innovation Research (SBIR) matching grant from the State of Illinois to continue develop of an innovative catheter device to improve the treatment of pulmonary embolism.

How the NSF I-Corps Program Helps MedTech Startups Succeed

The NSF I-Corps Program, created by the National Science Foundation, was designed to address this gap. Over time, it has become one of the most valuable early steps for medtech founders who want to validate their ideas before committing significant time and capital to development.

Demystifying FDA Medical Device Classification: A Comprehensive Guide

Ontogen Medtech collaborates with mHUB as supporting industry partner for Medtech Accelerator cohort

Differences Between MDD and MDR in Medical Device Regulation

In the European Union (EU), the regulation of medical devices has undergone a significant transformation with the transition from the Medical Device Directive (MDD) to the Medical Device Regulation (MDR). This shift aims to enhance the safety, performance, and traceability of medical devices within the EU market. Understanding the key differences between MDD and MDR is crucial for manufacturers, regulatory professionals, and other stakeholders in the medical device industry. This blog post explores these differences, emphasizing how they impact the development, approval, and post-market surveillance of medical devices.